ReviewCancers2023
Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints.
Dharmindra Dulal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ReviewCancers2023
Dharmindra Dulal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.